Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.

Smith DR, Weinstock-Guttman B, Cohen JA, Wei X, Gutmann C, Bakshi R, Olek M, Stone L, Greenberg S, Stuart D, Orav J, Stuart W, Weiner H.

Mult Scler. 2005 Oct;11(5):573-82.

PMID:
16193896
2.

Interferon beta-1a in MS: results following development of neutralizing antibodies in PRISMS.

Francis GS, Rice GP, Alsop JC; PRISMS Study Group.

Neurology. 2005 Jul 12;65(1):48-55.

PMID:
16009884
3.

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P.

N Engl J Med. 2005 Jul 28;353(4):362-8. Epub 2005 Jun 9.

4.

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.

Kleinschmidt-DeMasters BK, Tyler KL.

N Engl J Med. 2005 Jul 28;353(4):369-74. Epub 2005 Jun 9.

5.

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.

Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D.

N Engl J Med. 2005 Jul 28;353(4):375-81. Epub 2005 Jun 9.

6.

Childhood-juvenile multiple sclerosis: clinical characteristics and treatment.

Ghezzi A.

Expert Rev Neurother. 2005 May;5(3):403-11. Review.

PMID:
15938673
7.

Treatment of children and adolescents with multiple sclerosis.

Banwell B.

Expert Rev Neurother. 2005 May;5(3):391-401. Review.

PMID:
15938672
8.

Cognitive functioning in children and adolescents with multiple sclerosis.

MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, Preston TE, Cianciulli C, Krupp LB.

Neurology. 2005 Apr 26;64(8):1422-5.

PMID:
15851734
9.

Treatment of Pediatric Multiple Sclerosis.

Krupp LB, Macallister WS.

Curr Treat Options Neurol. 2005 May;7(3):191-199.

PMID:
15814072
10.

The cognitive burden of multiple sclerosis in children.

Banwell BL, Anderson PE.

Neurology. 2005 Mar 8;64(5):891-4.

PMID:
15753431
11.

Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a.

Pohl D, Rostasy K, Gärtner J, Hanefeld F.

Neurology. 2005 Mar 8;64(5):888-90.

PMID:
15753430
12.

Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan.

Shiraishi K, Higuchi Y, Ozawa K, Hao Q, Saida T.

Brain Dev. 2005 Apr;27(3):224-7.

PMID:
15737705
13.

Italian studies on early-onset multiple sclerosis: the present and the future.

Ghezzi A, Ruggieri M, Trojano M, Filippi M; ITEMS Study Group.

Neurol Sci. 2004 Nov;25 Suppl 4:S346-9. No abstract available.

PMID:
15727231
14.

Clinical characteristics of multiple sclerosis with early onset.

Ghezzi A.

Neurol Sci. 2004 Nov;25 Suppl 4:S336-9. Review.

PMID:
15727228
15.

Multiple sclerosis in children under 10 years of age.

Ruggieri M, Iannetti P, Polizzi A, Pavone L, Grimaldi LM; Italian Society of Paediatric Neurology Study Group on Childhood Multiple Sclerosis.

Neurol Sci. 2004 Nov;25 Suppl 4:S326-35. Review.

PMID:
15727227
16.

Atypical forms of multiple sclerosis or different phases of a same disease?

Trojano M, Paolicelli D, Bellacosa A, Fuiani A, Cataldi S, Di Monte E.

Neurol Sci. 2004 Nov;25 Suppl 4:S323-5.

PMID:
15727226
17.

IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS.

Sorensen PS, Haas J, Sellebjerg F, Olsson T, Ravnborg M; TARIMS Study Group.

Neurology. 2004 Dec 14;63(11):2028-33.

PMID:
15596745
18.

CSF characteristics in early-onset multiple sclerosis.

Pohl D, Rostasy K, Reiber H, Hanefeld F.

Neurology. 2004 Nov 23;63(10):1966-7.

PMID:
15557527
19.

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.

Hommes OR, Sørensen PS, Fazekas F, Enriquez MM, Koelmel HW, Fernandez O, Pozzilli C, O'Connor P.

Lancet. 2004 Sep 25-Oct 1;364(9440):1149-56.

PMID:
15451222
20.

MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood.

Mikaeloff Y, Adamsbaum C, Husson B, Vallée L, Ponsot G, Confavreux C, Tardieu M, Suissa S; KIDMUS Study Group on Radiology.

Brain. 2004 Sep;127(Pt 9):1942-7. Epub 2004 Aug 2.

PMID:
15289266

Supplemental Content

Support Center